MetaCap

Generate Biomedicines Statistics

NASDAQ: GENBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.54-0.83 (-8.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Generate Biomedicines by the numbers

Generate Biomedicines has a market capitalization of $1.23 billion based on 129.10M shares outstanding. With trailing EPS of $-2.49, Generate Biomedicines is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.8% below its 50-day average and 31.5% below its 200-day average.

Average daily trading volume is 1.24M shares, or about $11.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

GENB valuation vs. peer median

GENB compared with the median of 8 peer companies
MetricGENBPeer medianDifference
Market cap$1.23B$1.23B+0%
Avg. volume1.24M1.01M+22%

Peer median across 8 companies: SLN, OCUL, MNKD, MLYS, LBRX, AMPH, GHRS, AVLN.

Valuation

Price and trading

Previous close
10.37
Open
10.06
Day range
9.40 – 10.58
52-week range
9.40 – 22.67
Beta
—
Volume
967.20K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
1.23B
Forward Pe
-3.82
Eps
-2.49
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
22.67
Week52 Low
9.40
Avg Volume
1.24M
Shares Outstanding
129.10M
Ma50
13.79
Ma200
13.92
Earnings Date
Nov 12, 2026
Pct From52w High
-57.92%
Pct From52w Low
1.49%

Related